Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spire Healthcare operates the largest independent network of private hospitals in the UK by revenue. In 2024 it cared for over 1.3 million people across more than 38 hospitals and over 50 clinics. It delivers high standards of care with strong patient satisfaction ratings and has received multiple awards for clinical quality[1][2].
The company’s revenue streams include insured patients, self-pay patients, NHS contracts, corporate health services, mental health services, dermatology/musculoskeletal clinics, occupational health for corporate clients[1].
It was the first UK private hospital group to publish outcomes data on its website.
As of late 2024/early 2025 there are reports that Narayana Health may acquire a controlling stake but this has not been finalized[7].
No drug development or clinical trial pipeline exists as it does not develop therapeutics.
Recent financials show £1.51 billion in revenue for FY2024 with continued growth[2].
The company employs over 7,600 staff directly and works with more than 8,700 consultants[3][1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spire Healthcare.